You are here

Pharmaceutical Approval Update April 2008

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Topics include desvenlafaxine (Pristiq) for major depressive disorder in adults; rilonacept (Arcalyst) in treating inflammatory syndromes; and levocetirizine (Xyzal Oral Solution) for symptoms associated with allergic rhinitis and hives.